Previous 10 | Next 10 |
2023-11-17 12:26:47 ET DENVER, Colo., Nov. 17, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Altamira Therapeutics Ltd (NASDAQ: CYTO), Gap Inc (NYSE: GPS), Twist Bioscience Corp (NASDAQ: TWST), S...
2023-11-17 11:52:10 ET Twist Bioscience Corporation (TWST) Q4 2023 Results Conference Call November 17, 2023 08:00 AM ET Company Participants Angela Bitting - SVP, Corporate Affairs and Chief ESG Officer Dr. Emily Leproust - CEO and Co-Founder Jim Thorburn - Acti...
Twist Bioscience Corporation (NASDAQ: TWST) is one of today's top gainers. The company's shares have moved -0.27% on the day to $15.07. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables t...
2023-11-17 10:01:41 ET DENVER, Colo., Nov. 17, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Altamira Therapeutics Ltd (NASDAQ: CYTO), Twist Bioscience Corp (NASDAQ: TWST), Syntec Optics Holdings Inc (N...
2023-11-17 07:36:00 ET More on Twist Bioscience A New Look At Twist Bioscience Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand Twist Bioscience inks antibody research deal with Bayer Twist Bioscience in pact with Japan-based Ono for auto...
-- Record revenue of $245.1 million in Fiscal 2023; Increase of 20% over $203.6 million in Fiscal 2022 -- -- Orders increased to $264 million in Fiscal 2023; Increase of 17% over $226.4 million in Fiscal 2022 -- — Expect revenue in the range of $285 million to $290 million for full...
Bank of China Ltd. ADR (BACHY) is expected to report for Q2 2024 China Health Industries Holdings Inc (CHHE) is expected to report for quarter end 2023-09-30 Nitori Holdings Co., Ltd. ADR (NCLTY) is expected to report for Q2 2024 China Minsheng Banking Corporation Ltd. ADR (CMAKY) is ...
Twist Bioscience Corporation (TWST) is expected to report $-0.94 for Q4 2023
2023-11-16 11:53:39 ET More on Twist Bioscience A New Look At Twist Bioscience Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand Twist Bioscience inks antibody research deal with Bayer Twist Bioscience in pact with Japan-based Ono for auto...
Clonally perfect genes shipped in as few as five business days Launch of ‘fast genes’ enabled by state-of-the-art Wilsonville manufacturing facility Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qual...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...